About ReEngage Therapeutics
ReEngage Therapeutics is a private company based in Houston, Texas, incorporated in 2024 in Delaware. It has reported $430,000 raised in two offerings on Form D since December 2024. Its chief executive is Thomas Kim.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 2025 | Jun 18, 2025amended Jul 1, 2025 | $365,000of $8.0M target | 6 | $60,833 | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 9, 2024 | Dec 16, 2024 | $65,000of $3.0M target | 5 | $13,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $430,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ReEngage Therapeutics's Form D filed Jul 1, 2025.
TK